Literature DB >> 15840775

Impaired cytotoxicity in Papillon-Lefèvre syndrome.

T Lundgren1, R S Parhar, S Renvert, D N Tatakis.   

Abstract

Papillon-Lefèvre syndrome (PLS), palmoplantar hyperkeratosis with periodontitis, has been genetically characterized. However, suspected associated immune dysfunctions remain elusive. The purpose of this study was to evaluate peripheral blood lymphocyte levels and natural killer (NK) cell cytotoxicity in PLS. Twenty patients and 20 healthy controls were examined. Peripheral blood lymphocytes were analyzed by flow cytometry for surface markers. NK cell cytotoxicity against K562 cells was determined by means of a 51Cr release assay. White blood cell differential and proportions of B-, T-, T-helper, T-suppressor, and NK cells revealed only sporadic borderline variations from control values. In contrast, NK cell cytotoxicity was consistently and severely depressed (32-53% of control values) in all patients. To the best of our knowledge, this newly described impairment of NK cell cytotoxic function is the first consistent immune dysfunction reported in PLS. This suggests that the impaired NK cell cytotoxicity might contribute to the pathogenesis of PLS-associated periodontitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840775     DOI: 10.1177/154405910508400503

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  13 in total

1.  Papillon-Lefevre Syndrome In An Adolescent Female: A Case Study.

Authors:  M J Jijin; H P Jaishankar; Veena Sathya Narayaran; Krupashankar Rangaswamy; Kavitha Ankanathapura Puthaswamy
Journal:  J Clin Diagn Res       Date:  2015-05-01

2.  Papillon-lefevre syndrome.

Authors:  Mashkoor Ahmad; Iffat Hassan; Qazi Masood
Journal:  J Dermatol Case Rep       Date:  2009-12-30

3.  Cytokine production by leukocytes of Papillon-Lefèvre syndrome patients in whole blood cultures.

Authors:  Christian D Sadik; Barbara Noack; Beate Schacher; Josef Pfeilschifter; Heiko Mühl; Peter Eickholz
Journal:  Clin Oral Investig       Date:  2011-03-05       Impact factor: 3.573

4.  Long-Term Results after Placing Dental Implants in Patients with Papillon-Lefèvre Syndrome: Results 2.5-20 Years after Implant Insertion.

Authors:  Katrin Nickles; Mischa Krebs; Beate Schacher; Hari Petsos; Peter Eickholz
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

5.  Papillon-Lefevre syndrome: Reporting consanguinity as a risk factor.

Authors:  Aasim Farooq Shah; Pradeep Tangade; Swatantra Agarwal
Journal:  Saudi Dent J       Date:  2014-04-19

6.  Papillon-lefevre syndrome: a combined approach from the dermatologist and dentist - a clinical presentation.

Authors:  Radhika Muppa; B Prameela; Mahesh Duddu; Arthi Dandempally
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

7.  Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease.

Authors:  Stella Chaushu; Asaf Wilensky; Chamutal Gur; Lior Shapira; Moran Elboim; Gili Halftek; David Polak; Hagit Achdout; Gilad Bachrach; Ofer Mandelboim
Journal:  PLoS Pathog       Date:  2012-03-22       Impact factor: 6.823

Review 8.  Papillon-Lefèvre syndrome: clinical presentation and management options.

Authors:  Basapogu Sreeramulu; Naragani Dvn Shyam; Pilla Ajay; Pathipaka Suman
Journal:  Clin Cosmet Investig Dent       Date:  2015-07-15

9.  Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis.

Authors:  Vivien R Sutton; Nigel J Waterhouse; Kylie A Browne; Karin Sedelies; Annette Ciccone; Desiree Anthony; Aulikki Koskinen; Arno Mullbacher; Joseph A Trapani
Journal:  J Cell Biol       Date:  2007-02-05       Impact factor: 10.539

10.  Papillion-Lefèvre Syndrome: Periodontists' Perspective.

Authors:  Sunil Kumar Biraggari; K Krishna Mohana Reddy; J Sudhakar; Shiva Shankar Bugude; Rajesh Nichenametla; Mazher Ahmed Hakeem; Swati Reddy Tiyyagura
Journal:  Case Rep Dent       Date:  2015-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.